J Breast Cancer.  2013 Dec;16(4):357-365. 10.4048/jbc.2013.16.4.357.

Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer

• Kim H
• Choi DH

• KMID: 1976372
• DOI: http://doi.org/10.4048/jbc.2013.16.4.357

Abstract

Breast cancer is the most prevalent cancer in Asian females, and the incidence of breast cancer has been increasing in Asia. Because Asian patients develop breast cancer at a younger age than their Caucasian counterparts, the contributions of BRCA1 and BRCA2 (BRCA1/2) mutations in Asians are expected to be different than in Caucasians. The prevalence of BRCA1/2 mutations in the Asian population varies among countries and studies. Most Asian studies have reported more frequent mutations in BRCA2 than in BRCA1, with the exception of studies from India and Pakistan. In addition, the contribution of large genomic rearrangements of BRCA1/2 genes is relatively small in Asian populations in comparison to other ethnic populations. Various statistical models for the prediction of BRCA1/2 mutations have underestimated the risk of having these genetic mutations in Asians, especially in predicting BRCA2 gene mutation. Until recently, BRCA1/2 mutation analyses in Asia were mostly conducted by independent single institutions with different patient selection criteria and using various genotyping methods. However, a couple of Asian groups have initiated nationwide studies collecting BRCA1/2 mutational data. These national collaborative studies will help a comprehensive understanding of the prevalence of BRCA1/2 mutations in the Asian population.

Keyword

Asians; BRCA genes; Breast neoplasms

MeSH Terms

Asia
Asian Continental Ancestry Group*
Breast Neoplasms*
Breast*
Female
Genes, BRCA2
Humans
Incidence
India
Methods
Models, Statistical
Pakistan
Patient Selection
Prevalence